Tabata, Mika M <br/><br/>
Cardiotoxicity associated with immune checkpoint inhibitors in cutaneous oncology.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  04 2020 
 - 986-994 p.  digital 
<br/><br/> Publication Type: Letter; Review 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2019.08.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cardiotoxicity--epidemiology<br/>Humans<br/>Incidence<br/>Ipilimumab--adverse effects<br/>Nivolumab--adverse effects<br/>Skin Neoplasms--drug therapy